NYSE:THC - US88033G4073 - Common Stock
The current stock price of THC is 180.04 USD. In the past month the price increased by 15.37%. In the past year, price increased by 8.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 16.79 | 94.05B | ||
EHC | ENCOMPASS HEALTH CORP | 24.54 | 12.28B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 9.64 | 11.55B | ||
ENSG | ENSIGN GROUP INC/THE | 28.49 | 9.85B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 18.59 | 2.93B | ||
SGRY | SURGERY PARTNERS INC | 27.01 | 2.91B | ||
ACHC | ACADIA HEALTHCARE CO INC | 7.75 | 1.99B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.84B | ||
PACS | PACS GROUP INC | 15.34 | 1.81B | ||
ARDT | ARDENT HEALTH INC | 7 | 1.79B | ||
NHC | NATIONAL HEALTHCARE CORP | 16.6 | 1.73B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 12.11 | 1.59B |
Tenet Healthcare Corp. engages in the provision of healthcare services. The company is headquartered in Dallas, Texas and currently employs 74,480 full-time employees. The firm's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The firm's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. The company also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The firm operates a Global Business Center in the Philippines.
TENET HEALTHCARE CORP
14201 Dallas Parkway
Dallas TEXAS 75254 US
CEO: Ronald A. Rittenmeyer
Employees: 74480
Phone: 14698932200
The current stock price of THC is 180.04 USD. The price decreased by -0.11% in the last trading session.
The exchange symbol of TENET HEALTHCARE CORP is THC and it is listed on the New York Stock Exchange, Inc. exchange.
THC stock is listed on the New York Stock Exchange, Inc. exchange.
28 analysts have analysed THC and the average price target is 199.34 USD. This implies a price increase of 10.72% is expected in the next year compared to the current price of 180.04. Check the TENET HEALTHCARE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
TENET HEALTHCARE CORP (THC) has a market capitalization of 15.91B USD. This makes THC a Large Cap stock.
TENET HEALTHCARE CORP (THC) currently has 74480 employees.
TENET HEALTHCARE CORP (THC) has a support level at 171.32 and a resistance level at 180.05. Check the full technical report for a detailed analysis of THC support and resistance levels.
The Revenue of TENET HEALTHCARE CORP (THC) is expected to grow by 1.65% in the next year. Check the estimates tab for more information on the THC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
THC does not pay a dividend.
TENET HEALTHCARE CORP (THC) will report earnings on 2025-10-27, before the market open.
The PE ratio for TENET HEALTHCARE CORP (THC) is 12.21. This is based on the reported non-GAAP earnings per share of 14.75 and the current share price of 180.04 USD. Check the full fundamental report for a full analysis of the valuation metrics for THC.
The outstanding short interest for TENET HEALTHCARE CORP (THC) is 3.37% of its float. Check the ownership tab for more information on the THC short interest.
ChartMill assigns a technical rating of 8 / 10 to THC. When comparing the yearly performance of all stocks, THC turns out to be only a medium performer in the overall market: it outperformed 59.1% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to THC. While THC has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months THC reported a non-GAAP Earnings per Share(EPS) of 14.75. The EPS increased by 52.85% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.17% | ||
ROA | 5.17% | ||
ROE | 39.58% | ||
Debt/Equity | 3.49 |
28 analysts have analysed THC and the average price target is 199.34 USD. This implies a price increase of 10.72% is expected in the next year compared to the current price of 180.04.
For the next year, analysts expect an EPS growth of 32.9% and a revenue growth 1.65% for THC